0,593  0,029  Cyclophilin D inhibitor
0,593  0,029  Antidiabetic
0,547  0,010  Platelet antagonist
0,542  0,008  Antidiabetic symptomatic
0,531  0,003  GABA C receptor agonist
0,534  0,011  Antineurogenic pain
0,528  0,018  Ulceration
0,474  0,013  Acute neurologic disorders treatment
0,484  0,032  Stroke treatment
0,469  0,034  Antithrombotic
0,472  0,047  GST A substrate
0,468  0,044  5 Hydroxytryptamine release inhibitor
0,466  0,043  Calcium channel L-type activator
0,423  0,006  Tyrosine 3 hydroxylase inhibitor
0,413  0,004  NMDA receptor antagonist
0,445  0,043  GABA C receptor rho-3 antagonist
0,426  0,026  Antidiabetic (type 2)
0,445  0,053  Histamine release inhibitor
0,392  0,004  Excitatory amino acid transporter EAAC1 inhibitor
0,405  0,018  Platelet aggregation inhibitor
0,434  0,051  Atherosclerosis treatment
0,426  0,043  Antiallergic
0,429  0,056  Antipruritic, allergic
0,389  0,020  Sodium/bile acid cotransporter inhibitor
0,394  0,028  Antipyretic
0,360  0,008  Gastrin inhibitor
0,369  0,025  Peroxidase inhibitor
0,385  0,050  FMO1 substrate
0,419  0,084  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,336  0,005  Ferrochelatase inhibitor
0,358  0,028  Flavin-containing monooxygenase substrate
0,360  0,031  Insulysin inhibitor
0,368  0,039  UGT2B4 substrate
0,337  0,015  Restenosis treatment
0,324  0,004  Aldose reductase inhibitor
0,364  0,045  CTGF expression inhibitor
0,369  0,052  5 Hydroxytryptamine release stimulant
0,354  0,044  Interleukin 2 agonist
0,338  0,042  FMO3 substrate
0,343  0,052  CYP2C19 substrate
0,344  0,055  Lipoprotein disorders treatment
0,305  0,017  Allergic rhinitis treatment
0,324  0,043  Interleukin antagonist
0,337  0,059  Calcium channel activator
0,276  0,004  NMDA 2A receptor antagonist
0,345  0,083  CYP2C9 substrate
0,345  0,085  Antiasthmatic
0,268  0,013  Glutamate receptor antagonist
0,288  0,034  RNA-directed DNA polymerase inhibitor
0,334  0,081  Vasodilator, peripheral
0,255  0,004  NMDA receptor subunit 3A antagonist
0,257  0,006  GABA C receptor antagonist
0,301  0,052  Hypoglycemic
0,283  0,036  Antihypotensive
0,293  0,048  5 Hydroxytryptamine uptake stimulant
0,247  0,004  AMPA receptor antagonist
0,289  0,046  Cyclic AMP phosphodiesterase inhibitor
0,246  0,010  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,289  0,056  GST M1-1 substrate
0,249  0,017  Aldose reductase substrate
0,254  0,022  Alpha-N-acetylglucosaminidase inhibitor
0,328  0,098  Calpain 2 inhibitor
0,285  0,054  Hypolipemic
0,286  0,055  Interleukin agonist
0,233  0,004  NMDA receptor agonist
0,293  0,068  Aldehyde oxidase inhibitor
0,259  0,038  UGT2B7 substrate
0,223  0,004  Diacylglycerol O-acyltransferase 1 inhibitor
0,318  0,100  Toll-Like receptor agonist
0,250  0,032  Nitric-oxide synthase stimulant
0,255  0,038  Pneumotoxic
0,266  0,049  Antihypertriglyceridemic
0,355  0,141  Caspase 9 stimulant
0,220  0,008  NMDA 2 receptor antagonist
0,312  0,102  Toll-Like receptor 7 agonist
0,269  0,063  Cardiovascular analeptic
0,260  0,056  Antiulcerative
0,274  0,071  UGT1A9 substrate
0,209  0,006  Prostaglandin antagonist
0,254  0,056  Anticonvulsant
0,209  0,012  Contraceptive female
0,222  0,025  Interleukin 1 antagonist
0,290  0,096  ICAM1 expression inhibitor
0,236  0,042  Anticoagulant
0,199  0,008  GABA C receptor rho-1 antagonist
0,211  0,024  GABA C receptor rho-2 antagonist
0,221  0,034  Succinate dehydrogenase inhibitor
0,301  0,114  Immunosuppressant
0,190  0,004  Glycine receptor antagonist
0,238  0,052  Abortion inducer
0,227  0,042  Lipocortins synthesis antagonist
0,234  0,049  Antimigraine
0,189  0,004  Kainate receptor antagonist
0,208  0,023  Rhinitis treatment
0,239  0,055  Anesthetic general
0,211  0,028  Antifungal enhancer
0,233  0,050  Non-steroidal antiinflammatory agent
0,212  0,030  Uterine stimulant
0,183  0,003  Kainate receptor 2 antagonist
0,223  0,044  Age-related macular degeneration treatment
0,210  0,031  Insulin secretagoues
0,238  0,061  Antiparkinsonian, rigidity relieving
0,225  0,048  UGT1A4 substrate
0,263  0,087  Antihypoxic
0,206  0,032  Antirickettsial
0,205  0,037  UGT2B9 substrate
0,261  0,097  Antipsoriatic
0,183  0,021  Sphingosine 1-phosphate receptor 5 antagonist
0,238  0,077  Calpain inhibitor
0,164  0,004  GABA B receptor agonist
0,180  0,019  NAT2 substrate
0,165  0,007  3C-Like protease (SARS coronavirus) inhibitor
0,168  0,010  Antiviral (SARS coronavirus)
0,168  0,010  Antiviral (Coronavirus)
0,185  0,028  Antieczematic
0,176  0,019  Photosensitizer
0,173  0,017  Arylamine N-Acetyltransferase substrate
0,244  0,088  Chemoprotective
0,171  0,016  Alcohol dehydrogenase inhibitor
0,174  0,019  Adenylate kinase inhibitor
0,169  0,015  Prolactin inhibitor
0,157  0,004  NMDA receptor glycine site agonist
0,192  0,040  Arachidonic acid antagonist
0,169  0,017  Porphobilinogen synthase inhibitor
0,187  0,035  Antianemic
0,289  0,138  TNF expression inhibitor
0,196  0,046  Aldehyde oxidase substrate
0,212  0,062  Insulin sensitizer
0,248  0,100  CYP1A2 substrate
0,230  0,083  DNA synthesis inhibitor
0,150  0,004  AMPA 4 receptor antagonist
0,266  0,121  CYP3A4 substrate
0,151  0,006  NMDA receptor subunit 3B antagonist
0,208  0,067  UGT1A1 substrate
0,230  0,089  Superoxide dismutase inhibitor
0,186  0,047  Death-associated protein kinase 2 inhibitor
0,187  0,048  UGT2B10 substrate
0,162  0,024  HDL-cholesterol increasing
0,228  0,090  Antihypercholesterolemic
0,217  0,080  UGT1A6 substrate
0,169  0,033  Antihelmintic (Trematoda)
0,160  0,025  Sphingosine 1-phosphate receptor 4 antagonist
0,162  0,028  Choleretic
0,190  0,056  UGT1A3 substrate
0,169  0,036  Retinoprotector
0,147  0,015  Antidote, mercury
0,153  0,020  DOPA decarboxylase inhibitor
0,203  0,071  Sedative
0,180  0,048  CNS active muscle relaxant
0,204  0,073  Neurotrophic factor enhancer
0,155  0,024  HIV-1 integrase (Overall Integration) inhibitor
0,144  0,014  Peroxisome proliferator-activated receptor gamma agonist
0,269  0,140  Antiobesity
0,156  0,027  UGT2B1 substrate
0,174  0,045  SULT1A3 substrate
0,177  0,051  Contraceptive
0,224  0,098  Proliferative diseases treatment
0,176  0,052  Carcinogenic, group 1
0,127  0,003  Kainate receptor 1 antagonist
0,177  0,053  Neurotensin receptor agonist
0,145  0,021  Triose-phosphate isomerase inhibitor
0,178  0,055  Diuretic
0,145  0,022  Electrolyte absorption antagonist
0,249  0,126  Cholesterol antagonist
0,125  0,003  NMDA receptor glycine site antagonist
0,126  0,004  Vitronectin receptor antagonist
0,200  0,080  Psychostimulant
0,134  0,015  Phenylalanine 4-hydroxylase inhibitor
0,146  0,027  Catalase inhibitor
0,239  0,121  Bone diseases treatment
0,234  0,116  NOS3 expression inhibitor
0,121  0,004  Glutamate (mGluR4) antagonist
0,168  0,052  Antidiabetic (type 1)
0,316  0,200  Antiinflammatory
0,283  0,167  Antiarthritic
0,118  0,004  MDM2 inhibitor
0,189  0,075  VEGF expression inhibitor
0,118  0,004  Prostaglandin D2 antagonist
0,122  0,010  NMDA 2C receptor antagonist
0,175  0,064  ATPase inhibitor
0,152  0,040  Cystathionine beta-synthase inhibitor
0,151  0,040  Ca2+-transporting ATPase inhibitor
0,190  0,079  Antiviral (Ebola)
0,148  0,037  GABA receptor agonist
0,148  0,038  Aminopeptidase B inhibitor
0,115  0,005  Glutamate (mGluR group III) antagonist
0,115  0,005  SULT2A1 substrate
0,253  0,145  Antineoplastic (endocrine cancer)
0,224  0,116  Antiepileptic
0,158  0,051  Adenylate cyclase stimulant
0,143  0,039  SULT1A1 substrate
0,119  0,017  Sphingosine 1-phosphate receptor 4 agonist
0,124  0,024  Histidine decarboxylase inhibitor
0,124  0,025  Xanthine oxidase substrate
0,212  0,113  Immunostimulant
0,213  0,116  Antiosteoporotic
0,121  0,024  Restless leg syndrome treatment
0,100  0,003  Kainate receptor agonist
0,116  0,020  CDC25A inhibitor
0,111  0,016  Biliverdin reductase inhibitor
0,174  0,080  Antipruritic, non-allergic
0,106  0,012  Phosphorylase inhibitor
0,155  0,063  Antiparkinsonian, tremor relieving
0,168  0,076  Phospholipase C inhibitor
0,097  0,006  AMPA 1 receptor antagonist
0,099  0,009  Aconitate hydratase inhibitor
0,107  0,017  Argininosuccinate synthase inhibitor
0,095  0,006  Factor XIa inhibitor
0,175  0,088  UDP-glucuronosyltransferase substrate
0,229  0,143  Transcription factor NF kappa B inhibitor
0,110  0,024  Glutamate decarboxylase inhibitor
0,188  0,103  VCAM1 expression inhibitor
0,089  0,004  Free fatty acid receptor 1 agonist
0,102  0,017  GP IIb/IIIa receptor antagonist
0,179  0,095  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,116  0,033  Antispirochetal
0,129  0,046  Mucolytic
0,160  0,077  Cyclin-dependent kinase 3 inhibitor
0,158  0,078  Interleukin 6 antagonist
0,095  0,017  Androgen agonist
0,109  0,031  Dyspepsia treatment
0,113  0,036  Actinic keratosis treatment
0,142  0,067  Heat shock protein 70 antagonist
0,082  0,008  Antiviral (Hepatitis D)
0,088  0,016  Thromboxane antagonist
0,155  0,083  Growth hormone agonist
0,090  0,017  Glutamate (mGluR7) antagonist
0,083  0,011  Cholecystokinin antagonist
0,077  0,004  p53 inhibitor
0,088  0,017  Glutamate (mGluR6) antagonist
0,223  0,153  Apoptosis antagonist
0,165  0,095  Cytotoxic
0,082  0,014  Thromboxane A2 antagonist
0,073  0,005  AMPA 3 receptor antagonist
0,090  0,022  Phospholipase D inhibitor
0,143  0,075  Corneal wound healing stimulator
0,090  0,022  Prostaglandin EP2 antagonist
0,115  0,047  GST T1-1 substrate
0,127  0,059  Cholesterol synthesis inhibitor
0,075  0,008  Nociceptin (N/OFQ) receptor antagonist
0,081  0,014  Diacylglycerol O-acyltransferase inhibitor
0,096  0,030  Antiviral (RSV)
0,113  0,048  GST P1-1 substrate
0,105  0,039  NADH dehydrogenase inhibitor
0,105  0,040  Bile acid receptor antagonist
0,078  0,013  Thromboxane synthase inhibitor
0,153  0,089  Muscle relaxant
0,180  0,117  NOS2 expression inhibitor
0,172  0,109  Teratogen
0,116  0,053  Antiviral (Poxvirus)
0,094  0,031  Aminopeptidase I inhibitor
0,067  0,005  Sodium-dependent vitamin C transporter 2 inhibitor
0,069  0,009  GABA B receptor antagonist
0,080  0,020  Antihemophilic
0,128  0,068  Cyclooxygenase 3 inhibitor
0,094  0,034  Glutamate dehydrogenase inhibitor
0,130  0,071  Cyclooxygenase 1 inhibitor
0,088  0,030  Glycine receptor agonist
0,082  0,023  Alcohol oxidase inhibitor
0,154  0,095  3C-like protease (Human coronavirus) inhibitor
0,109  0,050  Creatine kinase inhibitor
0,063  0,005  Nociceptin (N/OFQ) receptor agonist
0,128  0,070  Vanilloid 1 agonist
0,109  0,052  UDP-glucose 4-epimerase inhibitor
0,124  0,068  Coagulant
0,137  0,082  Antimutagenic
0,137  0,083  Antifungal (Cryptococcus)
0,191  0,137  Antiviral (West Nile virus)
0,081  0,028  Carbamoyl phosphate synthetase inhibitor
0,070  0,017  DNA helicase inhibitor
0,080  0,027  Protease 3C (Human rhinovirus) inhibitor
0,086  0,034  Leukotriene synthesis inhibitor
0,119  0,068  Adenylate cyclase inhibitor
0,065  0,015  5-Alpha-reductase inhibitor
0,061  0,011  Squalene synthetase inhibitor
0,058  0,009  Glutamate (mGluR3) antagonist
0,101  0,053  Lanosterol 14 alpha demethylase inhibitor
0,061  0,014  Progesterone antagonist
0,151  0,104  Catenin beta inhibitor
0,096  0,050  Androgen antagonist
0,215  0,168  Vasodilator, coronary
0,117  0,071  Antifungal (Pneumocystis)
0,065  0,020  Sphingosine 1-phosphate receptor 5 agonist
0,116  0,071  Antineoplastic antimetabolite
0,054  0,009  Prostaglandin EP3 antagonist
0,052  0,007  GABA transporter 3 inhibitor
0,088  0,044  Cell adhesion molecule inhibitor
0,106  0,063  Mediator release inhibitor
0,083  0,039  Phosphofructokinase-1 inhibitor
0,052  0,008  GABA transporter 2 inhibitor
0,114  0,071  Interleukin 8 antagonist
0,060  0,018  Carnitine palmitoyltransferase 1B inhibitor
0,083  0,041  Antidote, organophosphates
0,072  0,030  Caspase 9 inhibitor
0,065  0,023  Integrin antagonist
0,046  0,005  Glutamate (mGluR1) agonist
0,083  0,043  GABA aminotransferase inhibitor
0,082  0,042  Cathepsin G inhibitor
0,083  0,043  Narcotic antagonist
0,050  0,010  Factor XI inhibitor
0,139  0,099  Antihelmintic (Nematodes)
0,106  0,067  Nav1.4 sodium channel blocker
0,149  0,110  Antihelmintic
0,090  0,051  Granulocyte macrophage colony stimulating factor agonist
0,049  0,010  Cholecystokinin B antagonist
0,125  0,087  Protein kinase stimulant
0,111  0,073  Cell adhesion inhibitor
0,135  0,097  Hexokinase inhibitor
0,098  0,061  UGT2B11 substrate
0,133  0,095  Eye irritation, high
0,070  0,032  Prostaglandin F2 alpha antagonist
0,198  0,161  AR expression inhibitor
0,086  0,050  Adrenaline agonist
0,109  0,073  TRPA1 agonist
0,080  0,045  Ankylosing spondylitis treatment
0,101  0,067  Expectorant
0,080  0,046  MAP kinase kinase 7 inhibitor
0,046  0,011  Free fatty acid receptor 1 antagonist
0,049  0,016  Membrane dipeptidase inhibitor
0,042  0,009  Kainate receptor 4 antagonist
0,037  0,004  Progesterone receptor B antagonist
0,124  0,092  UGT2B15 substrate
0,113  0,083  Antiviral (Influenza B)
0,067  0,037  Antiviral (Parainfluenza)
0,130  0,101  Phospholipase A2 inhibitor
0,114  0,085  Toll-Like receptor 2 antagonist
0,096  0,068  Glutamate (mGluR7) agonist
0,169  0,140  5 Hydroxytryptamine 3E antagonist
0,166  0,138  Cytostatic
0,044  0,017  Glutamate (mGluR8) agonist
0,068  0,041  Neutrophil collagenase inhibitor
0,123  0,095  Cell wall synthesis inhibitor
0,076  0,049  NAT1 substrate
0,061  0,034  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,143  0,116  Diabetic nephropathy treatment
0,040  0,013  Prostaglandin D2 agonist
0,041  0,014  AMPA 2 receptor antagonist
0,148  0,121  Embryotoxic
0,042  0,015  Glutamate (mGluR8) antagonist
0,091  0,065  Antiviral (Rhinovirus)
0,095  0,068  Carbonic anhydrase III inhibitor
0,132  0,106  Interferon gamma antagonist
0,047  0,021  Thymidine kinase inhibitor
0,056  0,030  Heparanase inhibitor
0,090  0,065  Potassium channel (Ca-activated) activator
0,051  0,026  Thymidylate synthase inhibitor
0,039  0,014  Prostaglandin agonist
0,112  0,087  Cathepsin H inhibitor
0,033  0,008  Integrin beta5 antagonist
0,105  0,081  Proteasome inhibitor
0,114  0,090  Antiviral (Papilloma)
0,072  0,049  Peroxisome proliferator-activated receptor gamma antagonist
0,057  0,035  Dihydroorotate oxidase inhibitor
0,124  0,102  Skeletal muscle relaxant
0,134  0,113  Nitric oxide antagonist
0,096  0,075  AMP-activated protein kinase stimulant
0,146  0,125  Antieczematic atopic
0,027  0,006  Kainate receptor 3 antagonist
0,104  0,083  Microtubule formation inhibitor
0,182  0,161  CYP2D6 substrate
0,107  0,087  Aldehyde dehydrogenase inhibitor
0,067  0,048  Andropause treatment
0,114  0,095  Cytokine production inhibitor
0,039  0,020  Fumarate hydratase inhibitor
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,124  0,106  Hemostatic
0,041  0,023  Cholecystokinin A antagonist
0,027  0,010  Kainate receptor 5 antagonist
0,081  0,064  Estrogen-related receptor beta agonist
0,043  0,026  Hypogonadism treatment
0,068  0,051  HIV-1 integrase inhibitor
0,024  0,008  Thymidine kinase (Herpes simplex virus 2) inhibitor
0,103  0,087  Caspase 3 inhibitor
0,028  0,013  Lysophosphatidic acid receptor 1 agonist
0,048  0,033  Aldosterone antagonist
0,117  0,102  Cyclooxygenase inhibitor
0,024  0,010  5-Alpha-reductase 1 inhibitor
0,025  0,010  5-Alpha-reductase 2 inhibitor
0,056  0,042  Pregnane X receptor antagonist
0,175  0,160  Amyotrophic lateral sclerosis treatment
0,090  0,076  Sulfotransferase substrate
0,018  0,004  3C-Like protease (MERS coronavirus) inhibitor
0,029  0,015  Nicotinic acid receptor 2 antagonist
0,116  0,102  Neurotrophic factor
0,024  0,011  Integrin beta3 antagonist
0,025  0,012  GRP78 expression inhibitor
0,049  0,036  Lysophosphatidic acid 3 receptor antagonist
0,048  0,036  Bombesin 2 receptor antagonist
0,027  0,014  Excitatory amino acid transporter 2 inhibitor
0,030  0,018  Uridine phosphorylase inhibitor
0,055  0,043  Postcoital contraceptive
0,080  0,068  D-Ala-D-Ala ligase inhibitor
0,090  0,078  Chronic obstructive bronchitis treatment
0,027  0,016  Thyroid hormone agonist
0,036  0,024  Tryptophan 5 hydroxylase inhibitor
0,090  0,079  Anabolic
0,119  0,108  Antidote
0,045  0,034  Beta adrenoreceptor agonist
0,024  0,013  Glutamate (mGluR1a) agonist
0,125  0,115  Pregnane X receptor agonist
0,051  0,041  Acyl-CoA dehydrogenase inhibitor
0,160  0,150  Heart failure treatment
0,016  0,007  Integrin beta6 antagonist
0,074  0,065  Carbonic anhydrase VI inhibitor
0,044  0,035  Opioid mu receptor agonist
0,027  0,018  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,165  0,157  Peptidyltransferase inhibitor
0,078  0,070  Factor XII inhibitor
0,034  0,026  Growth factor receptor-bound protein 2 antagonist
0,053  0,046  Glutamate (mGluR1) antagonist
0,034  0,027  Nicotinic acid receptor agonist
0,032  0,025  Peroxisome proliferator-activated receptor delta antagonist
0,011  0,004  Folate transporter 1 inhibitor
0,018  0,011  Vesicular glutamate transport inhibitor
0,033  0,026  RNA-directed RNA polymerase inhibitor
0,085  0,079  Carcinogenic, group 2B
0,033  0,027  Retinoid X alpha receptor antagonist
0,026  0,020  Lysine carboxypeptidase inhibitor
0,041  0,036  AICAR transformylase inhibitor
0,036  0,031  Retinoid X receptor antagonist
0,103  0,098  Antiacne
0,122  0,117  Raynaud's phenomenon treatment
0,021  0,016  GABA transporter inhibitor
0,047  0,042  Ornithine carbamoyltransferase inhibitor
0,077  0,073  Opioid antagonist
0,031  0,026  Glutamate (mGluR3) agonist
0,038  0,033  Liver X receptor alpha agonist
0,008  0,004  Integrin alpha5beta6 antagonist
0,035  0,030  Integrin alpha2 antagonist
0,127  0,123  Prostate disorders treatment
0,128  0,124  CF transmembrane conductance regulator agonist
0,053  0,050  Leukotriene C antagonist
0,031  0,027  Peroxisome proliferator-activated receptor delta agonist
0,025  0,022  Toll-Like receptor 4 agonist
0,025  0,021  Integrin alpha2beta1 antagonist
0,020  0,017  Integrin alphaVbeta3 antagonist
0,055  0,052  5 Hydroxytryptamine 2A agonist
0,010  0,007  Integrin alphaVbeta5 antagonist
0,069  0,067  Keratolytic
0,039  0,036  Cholesterol absorption inhibitor
0,012  0,010  Carbonic anhydrase XI inhibitor
0,077  0,075  CC chemokine 5 receptor agonist
0,065  0,062  Antibiotic
0,091  0,089  Antihelmintic (Fasciola)
0,038  0,036  Sphingosine 1-phosphate receptor 1 agonist
0,083  0,082  Protease inhibitor
0,029  0,027  Prostacyclin antagonist
0,069  0,067  Metalloproteinase-2 inhibitor
0,014  0,013  Thromboxane A2 agonist
0,099  0,098  Amylase inhibitor
0,104  0,102  Antihyperlipoproteinemic
0,016  0,015  Aminopeptidase A inhibitor
0,036  0,035  Dopamine D5 agonist
0,013  0,012  Integrin alphaVbeta6 antagonist
0,116  0,115  Thrombolytic
0,052  0,051  Carbonic anhydrase stimulant
0,015  0,014  Thyroid hormone alpha agonist
0,098  0,097  Aldehyde dehydrogenase substrate

